Insider Trading History of Reed Douglas Md

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Reed Douglas Md since 2007. The trader's CIK number is 1291262. At the time of the last reporting, Reed Douglas Md was the Director of G1 Therapeutics, Inc.. (stock ticker symbol GTHX). Also see all insider trading activities at G1 Therapeutics, Inc..

Note that in the past Reed Douglas MD also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Digirad Corp (DRAD) by Reed Douglas Md

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 DRAD 0 $0 100,000 $393,776 0 $0

Yearly summary of insider trading at Tetralogic Pharmaceuticals Corp (TLOG) by Reed Douglas Md

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 TLOG 142,857 $999,999 0 $0 0 $0

Yearly summary of insider trading at G1 Therapeutics, Inc. (GTHX) by Reed Douglas Md

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 GTHX 0 $0 837,500 $40,330,186 0 $0
2017 GTHX 133,333 $1,999,995 0 $0 0 $0


Insider trading activities at 3 companies by Reed Douglas Md:

1. Digirad Corp (DRAD)

2. Tetralogic Pharmaceuticals Corp (TLOG)

3. G1 Therapeutics, Inc. (GTHX)

Table 1. Insider trading of Digirad Corp (DRAD) by Reed Douglas Md

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-08-24 DRAD Sale 30,000 3.05 91,500
2007-05-24 DRAD Sale 2,100 4.40 9,240
2007-05-25 DRAD Sale 13,400 4.34 58,196
2007-05-29 DRAD Sale 54,500 4.31 234,840

Table 2. Insider trading of Tetralogic Pharmaceuticals Corp (TLOG) by Reed Douglas Md

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-12-17 TLOG Buy 142,857 7.00 999,999

Table 3. Insider trading of G1 Therapeutics, Inc. (GTHX) by Reed Douglas Md

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-05-30 GTHX Sale 800,000 48.00 38,400,000
2018-05-21 GTHX Sale 31,100 51.62 1,605,382
2018-05-22 GTHX Sale 5,900 50.77 299,554
2018-05-23 GTHX Sale 500 50.50 25,250
2017-05-22 GTHX Buy 133,333 15.00 1,999,995

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reed Douglas Md (Director of G1 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.